Jafron Biomedical Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '26 May 14, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Market Capitalization	15,061	15,232	22,720	17,755	24,741	42,653
Market Cap Growth	-21.26%	-32.96%	27.96%	-28.23%	-41.99%	-21.30%
Enterprise Value	13,671	14,176	21,627	16,803	23,822	41,394
Last Close Price	19.45	19.67	28.29	21.13	28.75	48.52
PE Ratio	26.32	28.59	27.70	40.68	27.81	35.64
Forward PE	24.01	19.57	20.91	20.46	14.20	31.28
PS Ratio	7.44	7.57	8.49	9.24	9.93	15.94
PB Ratio	4.07	4.39	6.81	5.63	6.89	12.61
P/TBV Ratio	4.19	4.53	7.04	5.85	7.20	13.27
P/FCF Ratio	27.62	27.76	27.85	26.52	60.65	59.91
P/OCF Ratio	21.27	21.12	21.62	19.37	27.99	34.14
EV/Sales Ratio	6.75	7.05	8.08	8.74	9.56	15.47
EV/EBITDA Ratio	15.95	17.17	19.28	29.30	23.92	30.15
EV/EBIT Ratio	18.50	20.01	21.67	34.79	25.71	31.27
EV/FCF Ratio	25.07	25.84	26.51	25.10	58.40	58.14
Debt / Equity Ratio	0.34	0.36	0.42	0.53	0.36	0.27
Debt / EBITDA Ratio	1.45	1.49	1.23	2.90	1.28	0.67
Debt / FCF Ratio	2.28	2.25	1.70	2.50	3.13	1.29
Net Debt / Equity Ratio	-0.38	-0.37	-0.28	-0.36	-0.36	-0.46
Net Debt / EBITDA Ratio	-1.63	-1.55	-0.83	-1.98	-1.29	-1.13
Net Debt / FCF Ratio	-2.55	-2.33	-1.14	-1.70	-3.14	-2.18
Asset Turnover	0.36	0.37	0.49	0.35	0.49	0.67
Inventory Turnover	1.54	1.40	1.44	1.07	1.61	2.54
Quick Ratio	7.75	5.10	3.10	3.49	3.91	7.21
Current Ratio	8.71	5.81	3.63	3.99	4.59	7.91
Return on Equity (ROE)	15.60%	15.62%	25.10%	12.63%	25.26%	38.47%
Return on Assets (ROA)	8.24%	8.21%	11.42%	5.51%	11.33%	20.61%
Return on Invested Capital (ROIC)	26.66%	24.84%	36.51%	18.25%	38.79%	56.14%
Return on Capital Employed (ROCE)	14.30%	14.40%	21.60%	10.20%	19.70%	29.90%
Earnings Yield	3.75%	3.50%	3.61%	2.46%	3.60%	2.81%
FCF Yield	3.62%	3.60%	3.59%	3.77%	1.65%	1.67%
Dividend Yield	2.61%	2.64%	2.83%	1.89%	2.33%	1.85%
Payout Ratio	113.94%	120.79%	41.47%	128.71%	82.00%	44.37%
Buyback Yield / Dilution	2.52%	1.14%	1.57%	0.08%	1.12%	0.89%
Total Shareholder Return	5.13%	3.79%	4.40%	1.97%	3.45%	2.74%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.